Locations:
Search IconSearch
August 20, 2024/Innovations

Strolll’s Collaboration with Cleveland Clinic Opens a New Phase in the Company’s Development

Under the terms of the $3 million agreement, Cleveland Clinic is taking an equity stake in Strolll. Additionally, a therapeutic tool developed by Cleveland Clinic will be integrated into the Strolll platform.

Young girl using augmented reality (AR) headset.

The United Kingdom's National Health Service (NHS), serving a population of 68 million, spent £239 billion in 2023, making up 11.1% of the gross national product. This represents both an opportunity and a challenge for startups in health and medical technology space as they seek to market new digital products to the U.K. health system. For instance, Strolll, a company that developed an augmented reality platform for neurological conditions, faced early financial constraints but managed to secure collaborations with the NHS and Cleveland Clinic.

The company's success was also attributed to the NHS's support for innovators, evidenced by various programs and initiatives designed to facilitate engagement with startups. The process from concept to reality involved extensive groundwork, research collaborations, and securing funding and regulatory approvals. The NHS's willingness to engage with young companies and its support programs played a crucial role in the company's progress. Strolll's collaboration with the NHS not only enabled it to gather clinical evidence and funding but also provided unique insights into the requirements and constraints of the healthcare system. The relationship between innovators and the UK health service has impacted the funding landscape, with grant money being readily available for companies in this sector. Moving forward, Strolll aims to focus on the U.S. market, although the U.K. health ecosystem remains a fertile ground for health tech companies, with significant investment flowing in, partly due to support from the NHS.

Stroll's collaboration with Cleveland Clinic marks an important milestone in the company's growth. The $3 million agreement involves Cleveland Clinic acquiring an equity stake in the U.K. company. Furthermore, a therapeutic tool created by Cleveland Clinic will be incorporated into the Stroll platform. With the use of augmented reality (AR), there is potential to expand its therapy services to patients' homes.

Read the full article via Forbes.

Subscribe to Cleveland Clinic Innovations' Newsletter

Follow Cleveland Clinic Innovations on LinkedIn

Latest from the Newsroom

Beri Ridgeway, M.D.

Cleveland Clinic Appoints Beri Ridgeway, M.D., as President of Cleveland Clinic London

Genediting Therapy Shows Success Against Severe Sickle Cell Disease

Gene Editing Therapy Shows Success Against Severe Sickle Cell Disease

Cleveland Clinic's Main Campus lobby

Mandel Foundation Donates $50 Million to Improve Access to Care at Cleveland Clinic

Blood pressure cuff

Experimental Monthly Injectable Reduces a Key Regulator of Blood Pressure

GLP-1 injection pen with a stethoscope

Tirzepatide Associated with Lower Risk of Heart and Kidney Damage Compared to Dulaglutide in Patients with Type 2 Diabetes and Cardiovascular Disease

Hospital Care At Home

Cleveland Clinic Introduces Hospital Care At Home in Ohio

Image of a scaled and tape measure

What Happens When Patients Stop Taking GLP-1 Drugs? New Cleveland Clinic Study Reveals Real World Insights

Illustration of digital medical records

AI-Driven Chart Review Accurately Identifies Potential Rare Disease Trial Participants in New Study